126 related articles for article (PubMed ID: 37851013)
21. Severity of oral mucositis in patients undergoing hematopoietic cell transplantation and an oral laser phototherapy protocol: a survey of 30 patients.
Eduardo FP; Bezinelli L; Luiz AC; Correa L; Vogel C; Eduardo CP
Photomed Laser Surg; 2009 Feb; 27(1):137-44. PubMed ID: 18699729
[TBL] [Abstract][Full Text] [Related]
22. Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation.
Nguyen DT; Shayani S; Palmer J; Dagis A; Forman SJ; Epstein J; Spielberger R
Support Care Cancer; 2015 Nov; 23(11):3141-7. PubMed ID: 25791390
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of a colostrum- and Aloe vera-based oral care protocol to prevent and treat severe oral mucositis in patients undergoing hematopoietic stem cell transplantation: a single-arm phase II study.
Guberti M; Botti S; Caffarri C; Cavuto S; Savoldi L; Fusco A; Merli F; Piredda M; De Marinis MG
Ann Hematol; 2022 Oct; 101(10):2325-2336. PubMed ID: 35922679
[TBL] [Abstract][Full Text] [Related]
24. Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.
Chen J; Seabrook J; Fulford A; Rajakumar I
J Oncol Pharm Pract; 2017 Mar; 23(2):116-120. PubMed ID: 26684614
[TBL] [Abstract][Full Text] [Related]
25. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
Freytes CO; Ratanatharathorn V; Taylor C; Abboud C; Chesser N; Restrepo A; Arango J; Odenheimer D
Clin Cancer Res; 2004 Dec; 10(24):8318-24. PubMed ID: 15623608
[TBL] [Abstract][Full Text] [Related]
26. Photobiomodulation: a promising innovative approach for preventing oral mucositis in patients undergoing hematopoietic stem cell transplantation.
Stocker N; Baltes V; Bellaiche S; Brouillard F; Belmoufid N; Rousseau C; Bonnin A; Van de Wyngaert Z; Ricard L; Banet A; Malard F; Duléry R; Mohty M; Brissot E
Support Care Cancer; 2022 Oct; 30(10):8211-8216. PubMed ID: 35810217
[TBL] [Abstract][Full Text] [Related]
27. Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation.
Wysocka-Słowik A; Gil L; Ślebioda Z; Kręgielczak A; Dorocka-Bobkowska B
Ann Hematol; 2021 Aug; 100(8):2079-2086. PubMed ID: 34117519
[TBL] [Abstract][Full Text] [Related]
28. Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation.
Hayashi H; Kobayashi R; Suzuki A; Ishihara M; Nakamura N; Kitagawa J; Kanemura N; Kasahara S; Kitaichi K; Hara T; Tsurumi H; Moriwaki H; Itoh Y
Anticancer Res; 2014 Dec; 34(12):7271-7. PubMed ID: 25503160
[TBL] [Abstract][Full Text] [Related]
29. Low-energy laser therapy for prevention of oral mucositis in hematopoietic stem cell transplantation.
Jaguar GC; Prado JD; Nishimoto IN; Pinheiro MC; de Castro DO; da Cruz Perez DE; Alves FA
Oral Dis; 2007 Nov; 13(6):538-43. PubMed ID: 17944669
[TBL] [Abstract][Full Text] [Related]
30. Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Ali M; Kerio AA; Khattak TA; Hussain M; Khan MA; Abbas Y
J Coll Physicians Surg Pak; 2023 Jul; 33(7):804-808. PubMed ID: 37401225
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of keratinocyte growth factor (palifermin) for prevention of oral mucositis in TBI-based allogeneic hematopoietic stem cell transplantation.
Schmidt V; Niederwieser D; Schenk T; Behre G; Klink A; Pfrepper C; Hinke A; Beelen DW; Junghanss C; Uharek L; Krüger WH; Hochhaus A; Sayer HG;
Bone Marrow Transplant; 2018 Sep; 53(9):1188-1192. PubMed ID: 29545592
[No Abstract] [Full Text] [Related]
32. Palifermin, administered for three doses only, reduces mucositis in patients undergoing HSCT and receiving chemoradiotherapy conditioning.
Coutsouvelis J; Dooley M; Kirkpatrick CM; Avery S; Hopkins R; Spencer A
Bone Marrow Transplant; 2022 Aug; 57(8):1329-1331. PubMed ID: 35589999
[No Abstract] [Full Text] [Related]
33. Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.
Legert KG; Remberger M; Ringdén O; Heimdahl A; Dahllöf G
Support Care Cancer; 2014 Aug; 22(8):2133-40. PubMed ID: 24647488
[TBL] [Abstract][Full Text] [Related]
34. Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experience.
Keefe D; Lees J; Horvath N
Support Care Cancer; 2006 Jun; 14(6):580-2. PubMed ID: 16775651
[TBL] [Abstract][Full Text] [Related]
35. Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update.
Patel P; Robinson PD; Baggott C; Gibson P; Ljungman G; Massey N; Ottaviani G; Phillips R; Revon-Rivière G; Treister N; White M; Cabral S; Dupuis L; Sung L
Eur J Cancer; 2021 Sep; 154():92-101. PubMed ID: 34252760
[TBL] [Abstract][Full Text] [Related]
36. Caphosol(®) mouthwash gives no additional protection against oral mucositis compared to cryotherapy alone in stem cell transplantation. A pilot study.
Svanberg A; Öhrn K; Birgegård G
Eur J Oncol Nurs; 2015 Feb; 19(1):50-3. PubMed ID: 25224595
[TBL] [Abstract][Full Text] [Related]
37. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation.
Gordon B; Spadinger A; Hodges E; Ruby E; Stanley R; Coccia P
J Clin Oncol; 1994 Sep; 12(9):1917-22. PubMed ID: 7916041
[TBL] [Abstract][Full Text] [Related]
38. Clinical assessment of oral mucositis and candidiasis compare to chemotherapic nadir in transplanted patients.
Patussi C; Sassi LM; Munhoz EC; Zanicotti RT; Schussel JL
Braz Oral Res; 2014; 28():1-7. PubMed ID: 25271965
[TBL] [Abstract][Full Text] [Related]
39. Parents and children's perceptions of distress related to oral mucositis during haematopoietic stem cell transplantation.
Kamsvåg-Magnusson T; Thorsell-Cederberg J; Svanberg A; von Essen L; Arvidson J; Mellgren K; Toporski J; Ljungman G
Acta Paediatr; 2014 Jun; 103(6):630-6. PubMed ID: 24612395
[TBL] [Abstract][Full Text] [Related]
40. A real-world accuracy of oral mucositis grading in patients undergoing hematopoietic stem cell transplantation.
Nakagaki M; Gavin NC; Clavarino A; Kennedy GA; Whitfield K
Support Care Cancer; 2022 Mar; 30(3):2705-2712. PubMed ID: 34822004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
